Apply Now

News » Archives » September 2017

The IDEA Center: Bringing Notre Dame's Best Ideas to Market

Author: Ryan Millbern

The newly launched IDEA Center plans to turn the innovations of 15 Notre Dame student and faculty researchers into viable commercial entities in the coming yea r— and to advance the common good in the process.    

  Read More

Harper Cancer Research Institute Community Seminar to focus on Breast Cancer Sept. 13

Author: Erin Blasko

Harper Cancer Feature

The Mike and Josie Harper Cancer Research Institute at the University of Notre Dame will host a community breast cancer seminar Sept. 13 (Wednesday) at Raclin-Carmichael Hall, 1234 N. Notre Dame Ave., as part of its occasional Community Seminar Series.

Doors open at 5 p.m., followed by presentations and a Q&A from 5:30 to 6:30 p.m. with Judy Nace, a local breast cancer survivor, and Jeni Prosperi, assistant professor of biochemistry and molecular biology at Indiana University School of Medicine-South Bend and adjunct assistant professor of biological sciences at Notre Dame. Read More

Faculty Seminar with Professor Siyuan Zhang

Author: Khoa Huynh

Zhang Seminar

Join Siuyan Zhang, the Nancy Dee Assistant Professor of Cancer Research and Assistant Professor of Biological Sciences at the University of Notre Dame, on Tuesday, October 10, 2017 at 4:00pm in 283 Galvin for a seminar titled Unraveling Bewildered Tumor Ecosystem – From Molecular Insights to Clinical Translation. Read More

Join Notre Dame Research for the 2017 Core Facility Fair

Author: Brandi Klingerman

Cff Pic

Notre Dame Research invites faculty, staff, post-doctoral scholars, graduate and undergraduate students, as well as external customers to attend the Core Facility Fair on Wednesday, September 20, 2017. From 12:00 to 4:00 p.m. in the McCourtney Hall B01 Auditorium, attendees will be able to learn how state-of-the-art instrumentation and expertise available via the University of Notre Dame core facilities can help take their research to the next level.  Read More

New Notre Dame ideas with potential to improve health and wellness secure funding

Author: Arnie Phifer

Research extends from the most common cause of heart attacks to a rare brain disorder affecting children

 

Vr4

The University of Notre Dame’s Advanced Diagnostics & Therapeutics (AD&T) initiative announced the recipients of its 2017 Discovery Fund awards, which provide seed funding to some of the most creative ideas being developed by Notre Dame faculty and their collaborators in areas of biomedical, environmental, and behavioral health.

 

Since 2013, AD&T has used its Discovery Fund program to support new projects identified by their scientific originality, multidisciplinary approaches, and likelihood to result in real-world applications and products.

 

“Our Discovery Fund awards have proven to be great investments,” says Paul Bohn, Schmitt Professor of Chemical and Biomolecular Engineering, Professor of Chemistry and Biochemistry, and Director of AD&T.

 

“Not only do we back faculty and students doing exciting, potentially transformative work, but so far every dollar we’ve invested has returned an additional $15 in external grant support. Many have also resulted in commercializable intellectual property. Those are the kinds of outcomes that produce long-term research sustainability.” Read More

Researchers tackle ovarian cancer using a multidisciplinary approach

Author: Deanna Csomo McCool

Sharon Stack, Ann F. Dunne and Elizabeth Riley Science Director of the Harper Cancer Research Institute and professor of chemistry and biochemistry

Researchers at the Harper Cancer Research Institute, which is a collaboration between the University of Notre Dame and the Indiana University School of Medicine South Bend (IUSM-SB), are working with community partners to not only foster awareness of ovarian cancer, but to develop tests for early detection, create novel chemotherapies, and target the Holy Grail: A cure. Read More

New End Point Strategy for Disease Elimination

Author: Sarah Craig

Edwinmichael 250

The University of Notre Dame’s Edwin Michael, Professor, Department of Biological Sciences and member of the Eck Institute for Global Health, and his team of researchers have developed a model to assess the utility of using dyethalcarbamazine (DEC) treated salt. Their research was recently published in Nature’s Scientific Reports, a peer-reviewed journal publishing topic areas and methods that address essential public health questions relating to infectious diseases of poverty. Read More